Catamaran reports Director election results

LISLE, IL, May 30, 2013 /CNW/ - Catamaran (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, today announced that the nominees listed in the Management Proxy Circular, dated April 1, 2013, for the 2013 Annual and Special Meeting of Shareholders (the "Meeting") were elected as Directors of the Company. At the Meeting, held on May 14, 2013, in Toronto, all resolutions put to vote were passed. The results of the vote for the election of Directors at the Meeting are as follows:

Nominees	Votes For		Votes Withheld
	Number	%	Number	%
Mark A. Thierer	101,871,377	96.86	3,299,080	3.14
Steven D. Cosler	104,282,132	99.16	888,325	0.84
Peter J. Bensen	103,645,760	98.55	1,524,697	1.45
William J. Davis	105,039,933	99.88	130,524	0.12
Steven B. Epstein	101,939,061	96.93	3,231,396	3.07
Betsy D. Holden	104,931,658	99.77	238,799	0.23
Karen L. Katen	103,683,767	98.59	1,486,690	1.41
Harry M. Kraemer	105,008,368	99.85	162,089	0.15
Anthony R. Masso	103,676,260	98.58	1,494,197	1.42

About Catamaran
Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 250 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada. For more information, please visit www.catamaranrx.com.

 

SOURCE: Catamaran

Tony Perkins
Investor Relations
Catamaran
[phone]
[email protected]